| Time | Pre-Congress Workshop 1 Kidney transplant immunopathology |
Pre-Congress Workshop 2 Organ donation & procurement |
Pre-Congress Workshop 3 Workup of potential transplant recipients |
|
| 0815 - 1000 |
Moderators: Mohamad Zaimi Wahab & Muhammad Iqbal Abdul Hafidz
|
Moderators: Haniza Omar & Lim Soo Kun |
Moderators: Halim Gafor & Rafidah Abdullah |
|
| 0815 - 0830 |
Course overview |
Course overview Diana Mohd Shah |
0815 – 0845
CKD burden in Asia
Vivekanand Jha |
|
| 0830 - 0900 |
0830 – 0915 The immune response to transplantation
|
Active donor detection in Spain. Is there a wrong or a right way to do it? Chloe Balleste |
||
| 0900 - 0930 | 0915 – 0930 BREAK |
Ancillary testing in brain death Gene Sung |
0845 – 0915
Economics of transplantation in Asia
Sunita Bavanandan |
|
| 0930 - 1000 | 0930 – 1015 Immune cells involved in transplantation rejection Lim Wai Hon |
Updates on donor maintenance to deliver quality organs for transplantation |
0915 – 0945
Optimising potential recipients for kidney transplantation
Vathsala Anantharaman |
|
| 1000 - 1030 | COFFEE BREAK | |||
| 1000 - 1200 | AST Council Meeting | |||
| 1030 - 1300 |
Moderators: Yee Seow Yeing & Maisarah Jalalonmuhali
|
Moderators: Esther Tan & Hirman Ismail |
Moderators: Yoong Boon Koon & Vijayan Manogran |
|
| 1030 - 1100 | 1030 – 1115 Pre-formed HLA Antibodies: Defining the Unacceptable Melissa Yeung |
Understanding refusals: what makes family consent? Omid Ghobadi |
Surgical aspects of kidney transplant recipients Murali Sundram |
|
| 1100 - 1130 | 1115 – 1145 Induction therapy Daniel Brennan |
Challenges in family donor conversation Sumana Navin and Sujatha Suriyamoorthi |
Consensus guideline on immunological evaluation of transplant recipients Jeremy Chapman |
|
| 1130 - 1200 | 1145 – 1200 BREAK |
Managing the original kidney disease Stephen Alexander |
||
| 1200 - 1230 | Desensitisation – HLA antibodies, ABOi transplantation Lim Soo Kun |
Challenges in making general hospitals organ donation-ready
Benita Padilla |
Pre-transplant cardiac evaluation Shaifali Sandal |
|
| 1230 - 1300 | Immunosuppressive drugs Romina Danguilan |
Normothermic machine perfusion for liver allograft Peter Friend |
Surgical aspects of liver transplant recipients Mohamed Rela |
|
| 1300 - 1400 | LUNCH | |||
| 1400 - 1700 |
Moderators: Halim Gafor & Lim Soo Kun
|
Moderators: Fairol Huda & Diana Mohd Shah |
Moderators: Wan Hazlina Wan Mohamad & Sharifah Shahnaz |
Moderators: Jeremy Chapman & Curie Ahn |
| 1400 - 1430 | Renal allograft histopathology: Banff Classification Mark Haas |
HCV and HIV positive donors Dorry Segev |
Pediatric renal recipient work-up Yap Hui Kim |
Vitallink Session I Greetings from international and regional leaders Jeremy Chapman, Samuel Lee, Marcelo Cantarovich, Ghazali Ahmad, Pandaan Batchuluun, Harun Ur Rashid, Khin Maung Htay, Hai An Ha Phan |
| 1430 - 1500 | T cell mediated rejection: diagnosis and management Kate Wyburn |
The power of social media and how it can affect organ donation Rafidah Abdullah |
What does the HLA crossmatch mean? Melissa Yeung |
Rules of organ allocation and distribution (20 minutes) Stefan Tullius |
Deceased organ donor management including DCD (20 minutes) Lee Jae Myeong |
||||
| 1500 - 1530 | 1500 – 1515 BREAK |
Organ donation and COVID-19: Clinical issues Marian Irazabal |
Frailty-assessment and prognosis Dorry Segev |
|
| Organ donation and COVID-19: World registries Maria Paula Gomez |
How to improve consent rate for deceased organ donation in hospitals? (20 minutes) Pandaan Batchuluun |
|||
| 1530 - 1600 | 1515 – 1545 Antibody mediated rejection: diagnosis and management Brian Nankivell |
i-DTI and telemedicine Estephan Arredondo Cordova |
Ethical issues in deceased organ donation and transplantation (20 minutes) Peter Stock |
|
| Artificial intelligence and robotics in organ donation Marian Irazabal |
Panel discussion (30 minutes) Speakers and advisors |
|||
| 1600 - 1630 | 1545 – 1630 Strategies for achieving tolerance Megan Sykes |
|||
| Closing comments Jeremy Chapman |
||||
| 1700 - 1740 | OPENING CEREMONY | |||
| Time | PLENARIES | |||
| 0900 - 0930 |
Plenary 1: Management of transplantation in the digital era
Chairperson: Halim Gafor |
|||
| 0930 - 1000 |
Plenary 2: The challenges of prolonging kidney allograft survival
Chairperson: Ghazali Ahmad |
|||
| 1000 - 1030 | COFFEE BREAK | |||
| 1030 - 1230 | STATE OF THE ART SYMPOSIUM (1) | |||
| Kidney transplant | Liver transplant | Heart & Lung | Donation & ethics | |
| 1030 - 1230 |
Chairpersons: Murali Sundram & Rosnawati Yahya
|
Chairpersons: Haniza Omar & Yoong Boon Koon |
Chairpersons: Mohd Nazeri Nordin & Ashari Yunus |
Chairpersons: Chandramalar T Santhirathelagan & Fan Kin Sing |
| 1030 - 1050 | Deceased donor kidney quality and allograft outcome Yang Jaeseok |
Epidemiology of non-alcoholic fatty liver and non-alcoholic steatohepatitis: implications for liver transplantation Dan Yock Young |
mTOR Inhibitors in heart transplantation Azmee Ghazi |
The Declaration of Istanbul on Organ Trafficking and Transplant Tourism 2018 Mustafa al-Mousawi |
| 1050 - 1110 | Causes of death with function – what can we do to prevent it? Steven Chadban |
Role of bridging therapies in acute and acute-on-chronic liver failures Shiv Kumar Sarin |
Pulmonary hypertension and lung transplantation Allan Glanville |
Importance of post donation care: a comparison of practices around the world Tina Coco |
| 1110 - 1130 | What is immunological risk? Roslyn Mannon |
Emerging indications for liver transplantation James Fung |
Bridging to lung transplantation: who, when and with what? |
Malaysia: curbing illegal overseas transplantation. Should we deny recipients of free immunosuppressants? Ghazali Ahmad |
| 1130 - 1150 | Trials in kidney transplantation Jonathan Craig |
Living donor liver transplantation for acute on chronic liver failure Subhash Gupta |
DCD – Euthanasia, withdrawal of therapy, reintubation…where do we draw the line? Chloe Balleste |
|
| 1150 - 1210 | Selection criteria for transplantation in HCC Kyung Suk Suh |
Opting in vs opting out: which works better? Marti Manyalich Vidal |
||
| 1210 - 1230 | ||||
| 1230 - 1400 |
Industry Sponsored Symposium (Astellas)
Chairperson: Rosnawati Yahya
1230 - 1235: Opening Remarks
Rosnawati Yahya
1235 - 1305: Improving Long-Term Outcomes in Managing Kidney Transplant Patient Lluis Guirado
1305 - 1325: Empower Patient with Education and Self-monitoring Tool (iCOMMIT App) Mohamad Zaimi
1325 - 1345: Q&A session All Faculty
1345 - 1350: Closing Rosnawati Yahya
|
|||
| 1400 - 1540 | ABSTRACT PRESENTATIONS (selected oral presentations) |
|||
| Kidney 1 | Basic Science | Organ Donation | Kidney 2 | |
|
Moderators: Philip Jeremiah
|
Moderators: Yee Seow Yeing |
Koong Jun Kit
|
Moderators: Lim Soo Kun |
|
| 1400 - 1410 |
Association between De Novo C1q-binding Donor Specific Antibodies and Clinical Outcomes after Kidney Transplantation: A Meta-Analysis |
The Efficacy of Human Amnion Membrane for the Treatment of Ischemia-impaired Wounds in a Rat Model. |
To Explore a Suitable Mode for Tissue Donation in China Based on a Provincial OPO |
The Pattern of Lymphocyte Subsets Among Transplant Recipients Who Required Hospitalization for Treatment of Any Source of Infection: A Single Tertiary Centre Experience |
| 1410 - 1420 |
Reduction of Symptom Burden in Kidney Transplant Recipients from Single Session Mindful Breathing: A Randomized Controlled Trial |
Distribution and Engraftment of Amnion Epithelial Cells After Intra-portal Infusion in a Rat Model |
Shanxi Provincial OPO: The First Independent Provincial OPO in China |
The Effect of Different Induction Regime on Serial Lymphocyte Subset in Post-Renal Transplant Recipients: A Single Tertiary Centre Experience |
| 1420 - 1430 |
Outcome of the Elderly Living Kidney Donors (eLKDs) in a Single Tertiary Center in Malaysia. |
Adeno-associated Viral Vector Mediated IL-10 Gene Transfer in Skin Allograft |
To Create the Era of Artificial Intelligence for Organ Donation and Transplantation Management |
Effect Modification of Eplet Mismatch in Different Tacrolimus Drug Level: Validation in Korean Nationwide Kidney Transplantation Cohort Data |
| 1430 - 1440 |
Clinical Significance of C3d Assay in Kidney Transplantation Recipients with Donor Specific Anti-HLA Antibodies |
Histomorphometric Analysis of Femoral and Sciatic Nerve Regeneration in a Rat Hindlimb Allotransplantation Model |
Temporal Trends in Brain Death Organ Donation in Asia: Results from the Global Observatory on Donation and Transplantation (GODT) |
Asian Society of Transplantation Registry Report on COVID-19 Infections in Kidney Transplant Recipients from Asia |
| 1440 - 1450 |
Post-Transplant MAG3 Scintigraphy in the Early Assessment of Renal Graft Function |
Human CD177 Suppresses the Neutrophil-mediated Xenocytotoxicity |
Barriers Toward Deceased Organ Donor Registration Among Indians Living in India and the United Kingdom: An Integrative Systematic Review Using Narrative Synthesis. |
Prevalence of Hepatitis E Among Kidney Transplant Recipients: A Single Tertiary Centre Experience |
| 1450 - 1500 |
A Survey of Patients and Donors' Perspectives in Resuming Deceased and Living Donor Kidney Transplantation in the COVID-19 Pandemic Era |
MICA Diversity and Linkage Disequilibrium with HLA Genes Among Malay Donors in Malaysian Stem Cell Registry (MSCR) |
Usefulness of Thiel's Embalmed Cadavers for Training in Organ Procurement |
Outcomes of Interleukine-2 Receptor Antagonist Induction Therapy in Standard-risk Renal Transplant Recipients Maintained on Tacrolimus - A Systematic Review and Meta-Analysis |
| 1500 - 1510 |
Kidney Donor Profile Index and Graft Outcome Among Deceased Donor Kidney Transplant Recipients in Malaysia |
Q&A Session |
The Impact of Educational Intervention on Attitude Towards Organ Donation Among Healthcare Workers in Five Hospitals in Malaysia |
Tacrolimus Metabolism Rate is a Major Determinant of Outcomes Among Kidney Transplant Recipients |
| 1510 - 1520 |
Application of Ex-vivo Normothermic Machine Perfusion (EVNMP) to Salvage a Discarded Kidney from an Uncontrolled Donation after Circulatory Determination of Death (DCD) with Successful Kidney Transplantation |
|
Death by Neurological Criteria in the Philippines: Levels of Awareness, Compliance and Obstacles to Brain Death Declaration |
Two Cases Using Hypoxia-inducible Factor Prolyl-Hydroxylase Inhibitor for Post-transplant Anemia |
| 1520 - 1530 |
The Relationship Between Klotho Gene and Cancer Occurrence in Kidney Transplant Recipients |
|
Outcome of Renal Transplantation in Children Given Ratg as Induction Therapy |
Is It Safe to Use Basiliximab Induction Therapies in High-Risk Renal Transplant Recipients under Tacrolimus-mycophenolate Mofetil Immunosuppression Era? |
| 1530 - 1540 |
Prevalence Rate of Proteinura and Metabolic Acidosis Among Renal Transplant Recipients in a Tertiary Teaching Hospital and Its Relationship to Dietary Intake |
|
The Outcomes of Renal Transplantation During the COVID-19 Pandemic. Is It Worth Doing?
Rehan Mohsin
|
Outcomes of Thymoglobulin Versus Basiliximab Induction Therapies in 2DR Mismatch Living-Donor Renal Transplant Recipients |
| Q&A Session | Q&A Session | Q&A Session | ||
| 1540 - 1610 | COFFEE BREAK | |||
| 1610 - 1640 |
Plenary 3: Chimerism, transplant tolerance and beyond
Chairperson: Goh Bak Leong |
|||
| 1640 - 1800 | DEBATES and STATE OF THE ART SYMPOSIUM (2) | |||
| Kidney - debates | Liver - debates | Heart & Lung | Transplantation and COVID-19 | |
| 1640 - 1800 |
Moderators: Esther Tan & Nurul Zaynah
|
Moderators: Haniza Omar & Yoong Boon Koon |
Chairpersons: Mohd Nazeri Nordin & Ashari Yunus |
Chairpersons: Vijayan Manogran & Maisarah Jalalonmuhali |
| 1640 - 1720 | Robotic renal transplantation vs Open renal transplantation – which is a better technique? Robotic: Pranjal Modi Open: Sandeep Guleria |
Active drinkers should be transplanted Pro: James Fung Con: Mohamed Rela |
Artificial intelligence in LVAD implantation David Luis Simon Morales (20 minutes) |
COVID-19: Results of the international survey Marcelo Cantarovich (20 minutes) |
| Late complications following lung transplantation Allan Glanville (20 minutes) |
||||
| 1720 - 1800 | Liver transplantation for liver metastasis Pro: Pal-Dag Line Con: Alfred Kow |
Living related lung transplant – Japanese model Hiroshi Date (20 minutes) |
Clinical presentation, complications, and outcomes in solid organ transplant recipients Madeleine Heldman (25 minutes) |
|
| Management of the transplant programme in the time of COVID-19 Hiroto Egawa (25 minutes) |
||||
| Time | PLENARIES AND REGISTRIES | |||
| 0800 - 0830 |
Plenary 4: Liver transplantation in metastatic liver disease
Chairperson: Mohanasundram Pillai Arumugam |
|||
| 0830 - 0900 |
Plenary 5: 50 donors p.m.p. is not a dream anymore: how did Spain do it?
Chairperson: Sunita Bavanandan |
|||
| 0900 - 1000 |
Asian transplantation registries for collaboration and harmony Chairpersons: Ong Loke Meng & Chandramalar T Santhirathelagan
0900-0915: What can we learn from registries? |
|||
| 1000 - 1030 | COFFEE BREAK | |||
| 1030 - 1230 | STATE OF THE ART SYMPOSIUM (3) | |||
| Kidney | Liver |
Astellas Named Symposium Donor and procurement |
Surgical aspects of kidney transplantation | |
| 1030 - 1230 |
Chairpersons: Lim Soo Kun & Rosnawati Yahya
|
Chairpersons: Haniza Omar & Mohanasundram Pillai Arumugam |
Chairpersons: Halim Gafor & Fan Kin Sing |
Chairpersons: Murali Sundram & Vijayan Manogran |
| 1030 - 1050 | T cell mediated rejection Sundaram Hariharan |
Current trends of immunosuppression in liver transplantation James Fung |
Organ donation innovative strategy in South East Asia (ODISSeA): what have we learnt? Muhammad Iqbal Abdul Hafidz |
The complex living donor Mustafa al-Mousawi |
| 1050 - 1110 | Management of ABMR: Current updates Kate Wyburn |
Acute liver failure and transplantation – indicators for poor outcome Subhash Gupta |
Deceased donation. should we allow donor family to meet recipients? Tina Coco |
The complex recipient Clarence Lei |
| 1110 - 1130 | Paired kidney exchange: success and challenges and lesson learnt Vivek Kute |
ABO incompatible liver transplantation Albert Chan |
Overcoming cultural barriers: is this the key to gaining consent? Katy Najafizadeh |
Role of interventional radiologist in kidney transplantation Basri Johan |
| 1130 - 1150 | ABO incompatible renal transplantation Kazunari Tanabe |
Role of Interventional radiology post liver transplant Basri Johan |
Increasing demand on master education for donation & transplantation. Marti Manyalich Vidal |
Coping with donor complications Sandeep Guleria |
| 1150 - 1210 | Burnout amongst donor coordinators: is it real? Sumana Navin |
When should I not proceed with kidney transplantation from a surgical perspective? Anant Kumar |
||
| 1210 - 1230 | ||||
| 1230 - 1400 |
Industry Sponsored Symposium (Novartis)
Chairperson: Muhammad Iqbal Abdul Hafidz
1230 - 1240 : Opening Remarks
Muhammad Iqbal Abdul Hafidz
1240 - 1330: Transforming transplantation using iBox predictive risk scoring system Marc Raynaud
1330 - 1400: Q&A session
|
|||
| 1400 - 1600 | STATE OF THE ART SYMPOSIUM (4) | |||
| Transplant immunology | Surgical aspects of liver transplantation | Transplant infectious disease | Biomarkers in transplantation | |
| 1400 - 1600 |
Chairpersons: Mohamad Zaimi Wahab & Wong Hin Seng
|
Chairpersons: Manisekar K Subramaniam & Yoong Boon Koon |
Chairpersons: Rafidah Abdullah & Philip Jeremiah |
Chairpersons: Sharifah Shahnaz & Muhammad Iqbal Abdul Hafidz |
| 1400 - 1420 | High resolution HLA typing in solid organ transplantation: is it necessary? Melissa Yeung |
Advances in surgical techniques in living donor liver transplantation Deniz Balci |
Asymptomatic bacteriuria post kidney transplantation: what to do Angela Webster |
Biomarkers in acute rejection Manikkam Suthanthiran |
| 1420 - 1440 | HLA mismatching and kidney transplant outcomes: what matters? Lim Wai Hon |
Laparoscopic living donor hepatectomy: safety and efficacy Alfred Kow |
Unusual infections from deceased donors Mustafa al-Mousawi |
Biomarkers in chronic allograft dysfunction Minnie Sarwal |
| 1440 - 1500 | Denovo DSA: risk factors and clinical consequences Kate Wyburn |
Long term liver transplant outcomes Albert Chan |
Difficult fungal infections: diagnostic approaches and management Vivek Kute |
Gut microbiome in solid organ transplantation Steven Chadban |
| 1500 - 1520 | Clinical relevance of non-HLA antibodies Minnie Sarwal |
Machine Perfusion in Liver Transplantation; the end of the ice age? Glenn Bonney |
Latent TB: detection and management Vivekanand Jha |
|
| 1520 - 1540 | Pediatric liver transplantation Mohamed Rela |
Respiratory viral infections in transplant recipients Atul Humar |
||
| 1540 - 1550 | ||||
| 1550 - 1620 | COFFEE BREAK | |||
| 1620 - 1800 | STATE OF THE ART SYMPOSIUM (5) | |||
| Kidney | Women in transplantation | Transplant immunology | Post-transplant complications | |
| 1620 - 1800 |
Chairpersons: Halim Gafor & Fairol Huda
|
Chairpersons: Yee Seow Yeing & Diana Mohd Shah |
Chairpersons: Esther Tan & Muhammad Iqbal Abdul Hafidz |
Chairpersons: Nurul Zaynah & Maisarah Jalalonmuhali |
| 1620 - 1640 | Belatacept in kidney transplant: past and future perspectives Lionel Rostaing |
Equity in donors and recipients in places with disparities Vathsala Anantharaman |
Eplet matching in kidney transplantation Lim Wai Hon |
Transplant-associated thrombotic microangiopathy - more than just clot and bleed Masaomi Nangaku |
| 1640 - 1700 | Optimising mycophenolic acid exposure in kidney transplant recipients: time for target concentration intervention Wong Hin Seng |
Equity in leadership Germaine Wong |
Role of DSA monitoring post kidney transplantation Christophe Legendre |
Post-transplant lymphoproliferative disorders Atul Humar |
| 1700 - 1720 | Can mTORi be combined with CNI in renal transplantation? Experimental and clinical evidence Yang Chul Woo |
Fertility and pregnancy post solid organ transplantation Maggie Ma |
The influence of immunosuppressive agents on the risk of denovo DSA in solid organ transplant recipients Lionel Rostaing |
Risk of cancer after solid organ transplant in childhood Jonathan Craig |
| 1720 - 1740 | Evolution of Banff Classification: 20 years ahead Brian Nankivell |
How women can bring change to organ transplantation - the Mongolian experience Lkhaakhuu Od-Erdene |
The role for inhibition of the CD40-CD154 pathway in co-stimulation blockade Lionel Rostaing |
Obesity and metabolic syndrome post transplantation: prevention and management Kim Yeong Hoon |
| 1740 - 1800 |
MicroRNA profiles predictive of organ allograft status
Manikkam Suthanthiran |
Panel Discussion and Q&A | ||
| 1800 - 1900 |
WIT Networking Event
|
|||
|
Chairpersons: Khin Thida Thwin & Yeong Hoon Kim |
||||
| Introduction to ASTREG-WIT-KT Project Miyeun Han (15 minutes) |
||||
| Panel Discussion and Q&A (15 minutes) | ||||
|
Chairperson: Roslyn Mannon
|
||||
| Introduction to WIT Pillar 3 Advocacy Bianca Davidson (15 minutes) |
||||
| Panel Discussion and Q&A (15 minutes) | ||||
| Time | PLENARIES | |||
| 0830 - 0900 |
Plenary 6: Experimental xenotransplantation
Chairpersons: Hirman Ismail |
|||
| 0900 - 1000 | STATE OF THE ART SYMPOSIUM (6) | |||
| Innovation in transplantation | Post-transplant complications | Asian experts in Transplantation | Women in transplantation | |
| 0900 - 1000 |
Chairpersons: Sunita Bavanandan & Diana Mohd Shah
|
Chairpersons: Suryati Yaakob & Fairol Huda |
Chairpersons: Mohd Nazeri Nordin & Philip Jeremiah |
Chairpersons: Rafidah Abdullah & Chandramalar T Santhirathelagan |
| 0900 - 0920 | Clinical transplantation: how do we measure performance? Steven Chadban |
Current strategies in post-transplant diabetes mellitus Masaomi Nangaku |
Translational research in transplantation Hideki Ohdan |
Gender balance in living donation - from the recipient's and donor's perspective
Allison Tong (15 minutes) Nicole Scholes-Robertson (15 minutes) Amanda Dominello (15 minutes) |
| 0920 - 0940 | Future of research in transplantation Jeremy Chapman |
Bone disease post transplantation: spectrum, impact, prevention and management Wong Jiunn |
Role of macrophages in transplant oncology and immunology Nancy Kwan Man |
|
| 0940 - 1000 |
(0945 - 1005) NOTTO-National Transplant Registry in India |
|||
| 1000 - 1030 | COFFEE BREAK |
(1005 - 1025) Pregnancy induced sensitisation and sex disparity in living donation |
||
| 1030 - 1230 | ABSTRACT PRESENTATIONS (selected oral presentations) |
Activity of deceased organ transplantation in Asia Vitallink Session II |
(1025 - 1055) Panel discussion |
|
| Kidney 3 | Basic Science 2 | |||
|
Moderators: Muhammad Iqbal Abdul Hafidz & Ng Kok Peng
|
Moderators: Teoh Chee Kiang & Esther Tan |
Chairpersons: Marcelo Cantarovich & Devinder Singh Rana |
||
| 1030 - 1040 |
Ulvan Ameliortes Kidney Ischemia-Reperfusion Injury in Mice Hyuk Jai Jang
|
Selective Inhibitor of iNOS Protects Against Hepatic Warm Ischemia and Reperfusion Injury-Induced Pulmonary Capillary Barrier Dysfunction Through Suppressing Matrix Metalloproteinase-9 |
Deceased Organ Transplantation in Asia Jeong Jong Cheol (20 minutes) |
|
| 1040 - 1050 |
The Utility of Combined Urine Urea and Creatinine Clearance for Pre-transplant Renal Function Assessment |
Protective roles of miR-34c in Hypoxia by Activating Autophagy Through BCL2 Repression |
Vietnam Hai An Ha Phan (10 minutes) |
|
| 1050 - 1100 |
Overview of HLA Class I and Class II Preformed Antibodies in Malaysian Renal Transplant Candidates |
Resveratrol Pretreatment Protects Against Myocardial Injury and Cardiac Dysfunction Induced by Hepatic Ischemia and Reperfusion Injury in Vascular Calcification Rat |
Myanmar Khin Maung Htay (10 minutes) |
|
| ABSTRACT PRESENTATIONS (selected oral presentations) |
||||
| Liver and Intestine | ||||
|
Moderators: Tan Soek Siam & Koong Jun Kit |
||||
| 1100 - 1110 |
Kidney Transplant Outcome with Pre-formed Donor Specific Antibodies: The Malaysian Data |
Resveratrol Administration Improves Hepatic Ischemia and Reperfusion Injury-Associated Long Term Left Ventricular Dysfunction and Ventricular-Arterial Coupling in Rats |
Bangladesh Harun Ur Rashid (10 minutes) |
A Single Center Experience of the Prognosis After Liver Transplantation from Discarded Graft Due to Poor Graft Conditions in Prioritized Centers Ho Joong Choi
|
| 1110 - 1120 |
Human Leukocyte Antigens (HLA) Mismatches and Kidney Transplant Outcomes in Malaysia |
Hepatoprotective Effects of Curcumin from Ischemia-Reperfusion Injury in Rats |
Indonesia Atma Gunawan (10 minutes) |
A Trade-off Between "Left at Right" and "Left at Left" Liver Transplantation |
| 1120 - 1130 | Whipple's Disease in Renal Transplant Recipients: A Single Center Experience from Pakistan Asma Nasim |
Baicalein Extract Reduces Hepatic Ischemia-Reperfusion Injury in Rats Min-Su Park |
Sri Lanka Ruwan Dissanayake (10 minutes) |
Steroid Resistant Rejection in Liver Transplantation; A Single Center Study for Risk Factor and Second Line Treatment Tae Yun Lee |
| 1130 - 1140 | Gram Negative Blood Stream Infection in Renal Transplant Recipients: Risk Factors and Outcome from a Transplant Center in Pakistan Asma Nasim |
Trans-Cinnamic Acid Ameliorates Hepatic Ischemia-Reperfusion Injury in Rat Min-Su Park |
Nepal Dibya Singh (10 minutes) |
The Impact of Immuneosuppressants on Gut Microbiome of Long-term Stable Patients After Liver Transplantation Soon Kyu Lee |
| 1140 - 1150 | The Utility of eGFR Equations in Assessing Renal Allograft Function: Are They Accurate? Lim Kai Wei |
Effect of Seed of Cassia Tora Against Hepatic Ischemia Reperfusion Injury Min-Su Park |
Pakistan Ejaz Ahmed (10 minutes) |
Impact of Donor and Recipient Age on Outcomes After Living-Donor Liver Transplantation Tsukasa Nakamura |
| 1150 - 1200 |
Impact of Donor-Recipient Age Combinations on Recipient Outcomes in Living Donor Kidney Transplantation |
Autologous Islet Transplantation in a Swine Model: A Preliminary Step in an Allogeneic Transplant Experiment |
Mongolia Battsegsev Gonchigjav (10 minutes) |
Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Living Donor Liver Transplant |
| 1200 - 1210 |
Prevalence and Predictive Factors of Delayed Graft Function Among Kidney Transplant Recipients in the Klang Valley |
Effect of Exenatide on a Swine Islet Autotransplantation Model |
Review and comments: How to achieve self-sufficiency in Asia? Marcelo Cantarovich (20 minutes) |
Clinical Significance of Mac-2 Binding Protein Glycosylated Isomers as a Surrogate Marker of Liver Graft Fibrosis After Pediatric Liver Transplantation. |
| 1210 - 1220 |
Is Compensation Prediction Score for Contralateral Kidney After Living Donor Kidney Donation Useful in the United States? |
Fucoidan Improve Outcomes in a Synergeneic Mouse Islet Transplant Model |
Long-Term Outcome Following Tacrolimus Related Neurotoxicity in Pediatric Living Related Liver Transplantation |
|
| 1220 - 1230 |
Significance of Natural Killer Cell Counts to Predict Allograft Rejections in Kidney Transplant Recipients |
Plasma Cell Rich Acute Rejections (PCARs) in Kidney Transplantation Immuno-Histological Study of 50 Cases.
Khawar Abbas
|
Panel Discussion Speakers |
Prevalence and Impact of Depression on Liver Donors Post-Transplant |
| Q&A Session | Q&A Session | |||
| 1230 - 1330 |
AST General Body Meeting |
(1230 - 1240) Prevalence and Impact of Mood Disorders on Liver Transplant Recipients - The Combat Against Depression. |
||
|
(1240 - 1250) Noninvasive Evaluations to Estimate Graft Steatosis in Living Donor Liver Transplantation for Donor Safety and Successful Outcome |
||||
|
(1250 - 1300) Early use of Everolimus as a Third Immunosuppresive Agent for Intestinal Transplantation (1300 - 1310) Q&A Session |
||||
| 1230 - 1400 |
Industry Sponsored Symposium (Takeda)
Prevention and management of CMV in 2021 1230 - 1235: Opening Remarks
1235 - 1255: Burden of CMV Infection/disease and risk factors among SOT recipients
Camille Kotton
1255 - 1315: Unmet needs and challenges in the management of CMV infection in the high-risk SOT
Steven Chadban
1315 - 1400: Managing post-transplant CMV infection: Case-based discussion
|
|||
| 1400 - 1510 | STATE OF THE ART SYMPOSIUM (7) and ROUNDTABLES | |||
| Transplantation in Asia – challenges & way forward | Transplant infectious diseases |
The ODISSeA project (Malaysia, Thailand, Myanmar, Philippines) |
||
| 1400 - 1510 |
Chairpersons: Hirman Ismail & Azmee Mohd Ghazi
|
Chairpersons: Lim Soo Kun & Maisarah Jalalonmuhali |
Chairpersons: Stephanie C. Andres & Maria Paula Gomez |
|
| 1400 - 1420 | Role of Vitallink in advancing transplantation in Asia Curie Ahn |
CMV: Consensus on monitoring, prevention, and therapeutic updates Atul Humar |
Panel discussion |
|
| 1420 - 1440 | Longest on waiting list vs fittest and shortest waiting time gets the kidney Rosnawati Yahya |
COVID-19: Vaccination in transplant recipients Dorry Segev |
||
| 1440 - 1500 | The Spanish model: can it be implemented in Asia? Chloe Balleste |
Hepatitis C: When is the optimal time to treat? Tan Soek Siam |
||
| 1500 - 1510 | ||||
| 1515 - 1600 | CLOSING CEREMONY & AWARDS CEREMONY | |||
(Updates as 20 July 2021)